Tumor-associated Lymph Node T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor-associated Lymph Node T Cell Therapy, covering 2024-12-03 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors [Phase 1]